#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
This would be something you did as a scientist, not necessarily as the chancellor. Not as the chancellor. The chancellors weren't doing this all the time.
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
This would be something you did as a scientist, not necessarily as the chancellor. Not as the chancellor. The chancellors weren't doing this all the time.
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
So then let's get to the next chapter. What all of a sudden in 2013, 2014 leads to the next transition to being the CEO of the Bill and Melinda Gates Foundation?
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
So then let's get to the next chapter. What all of a sudden in 2013, 2014 leads to the next transition to being the CEO of the Bill and Melinda Gates Foundation?
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
I assume that the rationale for that was obviously their focus is on global health. And you have the background in the clinical side, the research side, the epidemiologic side, the management side. So there's kind of those are four legs of a chair. Were there other things that I'm missing that they felt were kind of essential pillars?
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
I assume that the rationale for that was obviously their focus is on global health. And you have the background in the clinical side, the research side, the epidemiologic side, the management side. So there's kind of those are four legs of a chair. Were there other things that I'm missing that they felt were kind of essential pillars?
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
Okay. So you head up to Seattle now. Yes. When you show up to the foundation, how many employees are there? What does it look like? It's a not-for-profit, but does it run like Microsoft? I mean, how does it operate?
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
Okay. So you head up to Seattle now. Yes. When you show up to the foundation, how many employees are there? What does it look like? It's a not-for-profit, but does it run like Microsoft? I mean, how does it operate?